GlassScriptPhysician profile
Paul R Kemmeter
NPI 1548217946
$84,363.85
in general payments reported to CMS, 2019-2025
10 companies · $717 in 2025
The $717 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,847 · 2021: $8,890 · 2022: $33K · 2023: $16K · 2024: $2,025 · 2025: $717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $1,640 · Honoraria: $1,500 · Travel and Lodging: $409 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,510.00 |
| Food and Beverage | $1,640.07 |
| Honoraria | $1,500.00 |
| Travel and Lodging | $409.02 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $78,437.57 | 2019-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Medtronic, INC. | $3,521.15 | 2021-2024 | Signia, Ligasure |
| Richard Wolf Medical Instruments Corp. | $1,500.00 | 2024 | |
| Covidien LP | $617.17 | 2019-2020 | |
| Davol INC. | $158.41 | 2019 | |
| Intuitive Surgical, INC. | $45.21 | 2022-2023 | Da Vinci Surgical System |
| Braintree Laboratories, INC. | $30.51 | 2024-2025 | Suflave, Sutab |
| Micro-Tech Endoscopy USA, INC. | $28.14 | 2025 | Balloons |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2025 | Eohilia |
| Medtronic Minimed, INC. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kemmeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.